CD3D Gene Immunodeficiency Type 19 NGS Genetic DNA Test
Comprehensive Genetic Testing for Severe Immune Disorders
The CD3D Gene Immunodeficiency Type 19 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for severe combined immunodeficiency disorders. This advanced testing methodology provides crucial insights into the genetic basis of immune system dysfunction, enabling precise diagnosis and targeted treatment strategies for patients suffering from life-threatening immune deficiencies.
What This Test Measures and Detects
This sophisticated genetic analysis specifically targets mutations in the CD3D gene, which plays a critical role in T-cell receptor complex formation and function. The test utilizes next-generation sequencing technology to identify:
- Point mutations and small insertions/deletions in the CD3D gene
- Autosomal recessive inheritance patterns
- Genetic variants affecting T-cell development and maturation
- Mutations leading to complete or partial T-cell deficiency
- Specific genetic markers associated with immunodeficiency type 19
Who Should Consider This Test
This genetic test is particularly important for individuals presenting with:
- Recurrent, severe bacterial, viral, or fungal infections in infancy
- Failure to thrive and growth retardation
- Persistent diarrhea and malabsorption issues
- Family history of severe combined immunodeficiency
- Unexplained opportunistic infections
- Abnormal lymphocyte counts or T-cell function tests
- Consanguineous parentage with immune disorder history
Clinical Benefits of CD3D Genetic Testing
Undergoing CD3D gene testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out CD3D-related immunodeficiency
- Treatment Guidance: Informs decisions about bone marrow transplantation
- Family Planning: Enables genetic counseling for at-risk family members
- Early Intervention: Facilitates prompt treatment before severe complications develop
- Prognostic Information: Helps predict disease severity and progression
- Therapeutic Monitoring: Assists in evaluating treatment effectiveness
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert geneticists and immunologists:
- Positive Result: Indicates pathogenic mutations in the CD3D gene, confirming immunodeficiency type 19 diagnosis
- Negative Result: Suggests absence of CD3D mutations, though other genetic causes should be considered
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring
All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| CD3D Gene Immunodeficiency Type 19 NGS Genetic DNA Test – Discount Price | $500 |
| CD3D Gene Immunodeficiency Type 19 NGS Genetic DNA Test – Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of testing location.
Take Control of Your Health Today
Don’t let uncertainty about immune health concerns affect your quality of life. Our CD3D Gene Immunodeficiency Type 19 NGS Genetic DNA Test provides the clarity needed for informed medical decisions and personalized treatment approaches.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your immune health.
Our experienced genetic counselors are available to discuss your specific concerns, explain the testing process, and help you understand how this advanced genetic analysis can benefit your health journey. Early diagnosis through genetic testing can significantly improve treatment outcomes and quality of life for individuals with immune disorders.
